Skip directly to Accessibility Notice

How to Purchase

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    State Street Bank and Trust Company
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 01/23/20

  • 30-Day SEC Yield1

    1.46%
  • Total Net Assets

    $188.8M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.43%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly
  • Next Distribution Date

    03/31/2020

Key Points

  • Highly Liquid Companies 
    Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

  • Industry Leaders
    Index methodology favors the largest companies in the industry

  • Global Scope 
    Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    2,838,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.08%
  • Gross Expense Ratio

    0.43%
  • Fee Waivers and
    Expense Reimbursement

    -0.07%
  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2020. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 01/23/20

NAV/
Last Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
NAV
Chart
PPH $66.52
$66.49
59,092
133,916
-$0.22 / -0.33%
$-0.29 / -0.43%
+3.84%
+3.87%
$-0.03
-0.05%

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 3.35 13.42 19.14 19.14 9.06 1.99 -- 9.78
PPH (Share Price) 3.28 13.21 19.53 19.53 9.00 1.97 -- 9.90
MVPPHTR (Index) 3.59 13.67 18.77 18.77 9.00 1.96 -- 9.76
Performance Differential (NAV - Index) -0.24 -0.25 0.37 0.37 0.06 0.03 -- 0.02
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 3.35 13.42 19.14 19.14 9.06 1.99 -- 9.78
PPH (Share Price) 3.28 13.21 19.53 19.53 9.00 1.97 -- 9.90
MVPPHTR (Index) 3.59 13.67 18.77 18.77 9.00 1.96 -- 9.76
Performance Differential (NAV - Index) -0.24 -0.25 0.37 0.37 0.06 0.03 -- 0.02

Top 10 Holdings (%) as of 12/31/19 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
JOHNSON & JOHNSON
JNJ US
70,091
10,224,174 5.07
ASTRAZENECA PLC
AZN US
205,051
10,223,843 5.07
BRISTOL-MYERS SQUIBB CO
BMY US
158,330
10,163,203 5.04
PFIZER INC
PFE US
258,540
10,129,597 5.03
SANOFI
SNY US
201,620
10,121,324 5.02
MERCK & CO INC
MRK US
111,052
10,100,179 5.01
ABBVIE INC
ABBV US
113,972
10,091,081 5.01
NOVO NORDISK A/S
NVO US
173,785
10,058,676 4.99
NOVARTIS AG
NVS US
106,206
10,056,646 4.99
GLAXOSMITHKLINE PLC
GSK US
213,467
10,030,814 4.98
Top 10 Total (%) 50.21
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 12/31/19

  • Country

    % of Net Assets
  • United States

    62.00
  • United Kingdom

    11.19
  • France

    5.02
  • Denmark

    4.99
  • Switzerland

    4.99
  • Japan

    4.34
  • Israel

    4.32
  • Ireland

    3.29
  • Other/Cash

    -0.14

Sector Weightings (%) as of 12/31/19

  • Sector

    % of Net Assets
  • Health Care

    100.1
  • Other/Cash

    -0.1